What is the address of Dr. Yerma Coppens - Geriatrie?

The registered office of Dr. Yerma Coppens - Geriatrie is located at Zevensterrede 5, 9070 Destelbergen.

Is Dr. Yerma Coppens - Geriatrie still active?

Yes. According to the CBE (16 September 2026) Dr. Yerma Coppens - Geriatrie is active, legal situation “Normale toestand”, started on 28 November 2012.

Is Dr. Yerma Coppens - Geriatrie registered on Peppol?

Yes, Dr. Yerma Coppens - Geriatrie is registered on the Peppol network with ID 0208:0501828609.

What is the enterprise number of Dr. Yerma Coppens - Geriatrie?

The enterprise number of Dr. Yerma Coppens - Geriatrie is BE0501828609.

When was Dr. Yerma Coppens - Geriatrie founded?

Dr. Yerma Coppens - Geriatrie was founded on 28 November 2012.

Who are the directors of Dr. Yerma Coppens - Geriatrie?

According to the 2025 annual accounts, the directors of Dr. Yerma Coppens - Geriatrie are: Yerma Coppens.

Is Dr. Yerma Coppens - Geriatrie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 28 November 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Yerma Coppens - Geriatrie make in 2025?

Dr. Yerma Coppens - Geriatrie posted a profit after taxes of € 178,396 in financial year 2025.

What is the revenue of Dr. Yerma Coppens - Geriatrie?

As a small company, Dr. Yerma Coppens - Geriatrie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 278,821.

Dr. Yerma Coppens - Geriatrie (Private Limited)

Dossier Dr. Yerma Coppens - Geriatrie, printed on 16 September 2026 from databakkes.be/en/0501828609/dr-yerma-coppens-geriatrie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Yerma Coppens - Geriatrie from Destelbergen, company number BE0501828609, closed financial year 2025 with a result of € 178,396 after tax. For that financial year Dr. Yerma Coppens - Geriatrie recorded a gross margin of € 278,821 and equity of € 376,714. Compared with financial year 2024, the result moved from € 203,482 to € 178,396. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 9, 2026.

What it is worth Growing

€ 376,714

▲ 39% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 178,396

▼ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 194,014

▲ 86% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 73,224 paid out

41 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 4,935

▲ 69% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 425

▼ 93% vs 2024

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 55,463

▲ € 55,366 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 79,400

▲ 7% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 124,356 Gross margin 2022: € 124,356 First fiscal year in the series	€ 67,239 Gross margin 2023: € 67,239 ▼ 46% vs 2022 (€ 124,356) Unfavourable step	€ 311,928 Gross margin 2024: € 311,928 ▲ € 244,689 vs 2023 (€ 67,239) Favourable step	€ 278,821 Gross margin 2025: € 278,821 ▼ 11% vs 2024 (€ 311,928) Unfavourable step	▼ 11%
Profit after taxes	€ 63,418 Profit after taxes 2022: € 63,418 First fiscal year in the series	€ 34,888 Profit after taxes 2023: € 34,888 ▼ 45% vs 2022 (€ 63,418) Unfavourable step	€ 203,482 Profit after taxes 2024: € 203,482 ▲ € 168,594 vs 2023 (€ 34,888) Favourable step	€ 178,396 Profit after taxes 2025: € 178,396 ▼ 12% vs 2024 (€ 203,482) Unfavourable step	▼ 12%
Equity	€ 61,772 Equity 2022: € 61,772 First fiscal year in the series	€ 96,660 Equity 2023: € 96,660 ▲ 56% vs 2022 (€ 61,772) Favourable step	€ 271,542 Equity 2024: € 271,542 ▲ 181% vs 2023 (€ 96,660) Favourable step	€ 376,714 Equity 2025: € 376,714 ▲ 39% vs 2024 (€ 271,542) Favourable step	▲ 39%
Total debts	€ 146,025 Total debts 2022: € 146,025 First fiscal year in the series	€ 87,438 Total debts 2023: € 87,438 ▼ 40% vs 2022 (€ 146,025) Favourable step	€ 153,234 Total debts 2024: € 153,234 ▲ 75% vs 2023 (€ 87,438) Unfavourable step	€ 155,380 Total debts 2025: € 155,380 ▲ 1% vs 2024 (€ 153,234) Unfavourable step	▲ 1%
Cash	€ 110,266 Cash 2022: € 110,266 First fiscal year in the series	€ 9,813 Cash 2023: € 9,813 ▼ 91% vs 2022 (€ 110,266) Unfavourable step	€ 104,503 Cash 2024: € 104,503 ▲ € 94,690 vs 2023 (€ 9,813) Favourable step	€ 194,014 Cash 2025: € 194,014 ▲ 86% vs 2024 (€ 104,503) Favourable step	▲ 86%
Retained profit	€ 43,172 Retained profit 2022: € 43,172 First fiscal year in the series	€ 78,060 Retained profit 2023: € 78,060 ▲ 81% vs 2022 (€ 43,172) Favourable step	€ 252,942 Retained profit 2024: € 252,942 ▲ 224% vs 2023 (€ 78,060) Favourable step	€ 358,114 Retained profit 2025: € 358,114 ▲ 42% vs 2024 (€ 252,942) Favourable step	▲ 42%
Dividend	€ 88,594 Dividend 2022: € 88,594 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 88,594) Unchanged	€ 28,600 Dividend 2024: € 28,600 Unchanged (€ 0) Unchanged	€ 73,224 Dividend 2025: € 73,224 ▲ 156% vs 2024 (€ 28,600) Unchanged	▲ 156%
Bank debt	€ 17,083 Bank debt 2022: € 17,083 First fiscal year in the series	€ 10,252 Bank debt 2023: € 10,252 ▼ 40% vs 2022 (€ 17,083) Favourable step	€ 6,124 Bank debt 2024: € 6,124 ▼ 40% vs 2023 (€ 10,252) Favourable step	€ 425 Bank debt 2025: € 425 ▼ 93% vs 2024 (€ 6,124) Favourable step	▼ 93%
Balance sheet total	€ 207,797 Balance sheet total 2022: € 207,797 First fiscal year in the series	€ 184,098 Balance sheet total 2023: € 184,098 ▼ 11% vs 2022 (€ 207,797) Unchanged	€ 424,776 Balance sheet total 2024: € 424,776 ▲ 131% vs 2023 (€ 184,098) Unchanged	€ 532,094 Balance sheet total 2025: € 532,094 ▲ 25% vs 2024 (€ 424,776) Unchanged	▲ 25%

Key figures of Dr. Yerma Coppens - Geriatrie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Yerma Coppens - Geriatrie?

What happened at Dr. Yerma Coppens - Geriatrie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 9, 2026 New annual accounts for financial year 2025: profit of € 178,396 (▼ 12% vs 2024). Source: NBB ↗
Dec 19, 2012 New establishment in Destelbergen. KBO
2012 Yerma Coppens became a director. NBB
Nov 28, 2012 Start of the company according to the CBE. KBO

In short

From € 63,418 profit in 2022 to € 178,396 profit in 2025.

Paid € 223,626 in corporate taxes since 2022.

Best year ever: 2024, with € 203,482 profit.

Paid out € 190,419 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Yerma Coppens - Geriatrie? We notify you, reason included.

Follow Dr. Yerma Coppens - Geriatrie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Yerma Coppens

Dr. Yerma Coppens - Geriatrie

Behind Dr. Yerma Coppens - Geriatrie is Yerma Coppens.

See the full network in the app

Directors

According to the 2025 annual accounts

Yerma Coppens

Director

since 2012

Establishments

Establishment units

Physical locations of this company

Registered office

Zevensterrede 5

9070 Destelbergen

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0501.828.609
VAT number: BE 0501.828.609
Registered office: Zevensterrede 5, 9070 Destelbergen
Names & denominations: Dr. Yerma Coppens - Geriatrie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 28 November 2012
Peppol: Active · Active since 3 Dec 2025

View on CBE Public ↗ Annual accounts (NBB) ↗